Chad M. Robins, CEO and Chairman at Adaptive Biotechnologies Corp (ADPT), sold 95,820 shares at $60.71 ($5.7M) on 2020-12-28, disclosed to the SEC on 2020-12-30.
Open-market sale of $5.7M ADPT by CEO and Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.71 | 13,542 | $822K | 14.3% |
| 2 | $60.71 | 13,542 | $822K | 14.3% |
| 3 | $61.48 | 1,108 | $68K | 1.2% |
| 4 | $61.48 | 1,108 | $68K | 1.2% |
| 5 | $62.60 | 1,500 | $94K | 1.6% |
| 6 | $63.41 | 100 |
| $6K |
| 0.1% |
| 7 | $58.87 | 8,256 | $486K | 8.5% |
| 8 | $58.87 | 8,256 | $486K | 8.5% |
| 9 | $59.42 | 6,834 | $406K | 7.1% |
| 10 | $59.42 | 6,834 | $406K | 7.1% |
| 11 | $60.73 | 1,700 | $103K | 1.8% |
| 12 | $59.20 | 7,651 | $453K | 7.9% |
| 13 | $59.20 | 7,651 | $453K | 7.9% |
| 14 | $59.65 | 8,869 | $529K | 9.2% |
| 15 | $59.65 | 8,869 | $529K | 9.2% |
| Total | $59.82 avg | 95,820 | $5.7M | 100% |
| Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |
| ADPT | SELL | 2026-03-03 | $8.3M | — | Filing → |
| ADPT | SELL | 2026-02-04 | $2.3M | — | Filing → |